The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 37,482 | 953,500 | SH | SOLE | 953,500 | 0 | 0 | ||
Abbott Laboratories | Common | 002824100 | 4,866 | 123,800 | SH | Call | SOLE | 247,600 | 0 | 0 | |
AbbVie Inc. | Common | 00287Y109 | 10 | 156 | SH | SOLE | 156 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 11,802 | 363,585 | SH | SOLE | 363,585 | 0 | 0 | ||
Accelerate Diagnostics, Inc. | Common | 00430H102 | 3,808 | 264,625 | SH | SOLE | 264,625 | 0 | 0 | ||
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 2,420 | 296,934 | SH | SOLE | 296,934 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Note 2.00% 8/15/19 | 00767EAB8 | 7,410 | 13,000,000 | PRN | SOLE | 13,000,000 | 0 | 0 | ||
Affimed NV | Common | N01045108 | 730 | 294,213 | SH | SOLE | 294,213 | 0 | 0 | ||
Agilent Technologies, Inc. | Common | 00846U101 | 21,978 | 495,450 | SH | SOLE | 495,450 | 0 | 0 | ||
Akorn, Inc. | Common | 009728106 | 6,986 | 245,235 | SH | SOLE | 245,235 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 79,608 | 681,805 | SH | SOLE | 681,805 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 29,988 | 693,844 | SH | SOLE | 693,844 | 0 | 0 | ||
Alkermes plc | Common | G01767105 | 4,836 | 111,900 | SH | Call | SOLE | 111,900 | 0 | 0 | |
Allergan plc | Common | G0177J108 | 107,199 | 463,886 | SH | SOLE | 463,886 | 0 | 0 | ||
Allergan plc | Preferred Convertible | G0177J116 | 4,168 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
Alliqua BioMedical, Inc. | Common | 019621200 | 1,848 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 2,205 | 173,600 | SH | SOLE | 173,600 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 13,539 | 243,995 | SH | SOLE | 243,995 | 0 | 0 | ||
AmerisourceBergen Corporation | Common | 03073E105 | 29,864 | 376,500 | SH | SOLE | 376,500 | 0 | 0 | ||
AmerisourceBergen Corporation | Common | 03073E105 | 3,292 | 41,500 | SH | Call | SOLE | 41,500 | 0 | 0 | |
Amgen Inc. | Common | 031162100 | 50,474 | 331,740 | SH | SOLE | 331,740 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 1,537 | 10,100 | SH | Call | SOLE | 10,100 | 0 | 0 | |
Amicus Therapeutics, Inc. | Common | 03152W109 | 1,409 | 258,000 | SH | SOLE | 258,000 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y407 | 2,353 | 811,227 | SH | SOLE | 811,227 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 12,129 | 1,389,370 | SH | SOLE | 1,389,370 | 0 | 0 | ||
ARIAD Pharmaceuticals Inc. | Common | 04033A100 | 3,710 | 502,000 | SH | SOLE | 502,000 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 3,327 | 110,200 | SH | Call | SOLE | 110,200 | 0 | 0 | |
AstraZeneca PLC | Sponsored ADR | 046353108 | 17,329 | 574,000 | SH | SOLE | 574,000 | 0 | 0 | ||
Auris Medical Holding AG | Common | H03579101 | 3,496 | 834,263 | SH | SOLE | 834,263 | 0 | 0 | ||
BeiGene Ltd. | Sponsored ADR | 07725L102 | 3,478 | 116,707 | SH | SOLE | 116,707 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 778 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 108,948 | 450,533 | SH | SOLE | 450,533 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 50,869 | 653,845 | SH | SOLE | 653,845 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 4,489 | 57,700 | SH | Call | SOLE | 57,700 | 0 | 0 | |
bluebird bio, Inc. | Common | 09609G100 | 2,136 | 49,345 | SH | SOLE | 49,345 | 0 | 0 | ||
Bristol-Myers Squibb Co. | Common | ADI0M9WV6 | 6,421 | 87,300 | SH | Put | SOLE | 87,300 | 0 | 0 | |
Care Capital Properties, Inc. | Common | 141624106 | 2,210 | 84,316 | SH | SOLE | 84,316 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 137,963 | 1,398,789 | SH | SOLE | 1,398,789 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 3,077 | 31,200 | SH | Call | SOLE | 31,200 | 0 | 0 | |
Celldex Therapeutics, Inc. | Common | 15117B103 | 464 | 105,800 | SH | SOLE | 105,800 | 0 | 0 | ||
Cellectis S.A. | Sponsored ADS | 15117K103 | 8,250 | 310,250 | SH | SOLE | 310,250 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 8,564 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
Cepheid, Inc. | Common | 15670R107 | 10,258 | 333,590 | SH | SOLE | 333,590 | 0 | 0 | ||
Cepheid, Inc. | Note 1.25% 2/1/21 | 15670RAC1 | 8,669 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
Chimerix, Inc. | Common | 16934W106 | 1,214 | 308,892 | SH | SOLE | 308,892 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 1,366 | 132,472 | SH | SOLE | 132,472 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 3,669 | 304,472 | SH | SOLE | 304,472 | 0 | 0 | ||
Corsicanto Ltd | Note 3.50% 1/15/32 | 220480AB3 | 14,930 | 14,700,000 | PRN | SOLE | 14,700,000 | 0 | 0 | ||
CVS Caremark Corporation | Common | 126650100 | 21,435 | 223,891 | SH | SOLE | 223,891 | 0 | 0 | ||
Cynapsus Therapeutics, Inc. | Common | 23257Y859 | 7,708 | 460,207 | SH | SOLE | 460,207 | 0 | 0 | ||
CytomX Therapeutics, Inc. | Common | 23284F105 | 7,723 | 756,090 | SH | SOLE | 756,090 | 0 | 0 | ||
DBV Technologies S.A. | Sponsored ADR | 23306J101 | 2,140 | 65,600 | SH | SOLE | 65,600 | 0 | 0 | ||
Depomed Inc. | Common | 249908104 | 3,924 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Dynavax Technologies Corporation | Common | 268158201 | 5,031 | 345,050 | SH | SOLE | 345,050 | 0 | 0 | ||
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 5,281 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
Eli Lilly and Company | Common | 532457108 | 39,577 | 502,567 | SH | SOLE | 502,567 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 4,464 | 286,348 | SH | SOLE | 286,348 | 0 | 0 | ||
Endologix Inc. | Common | 29266S106 | 6,865 | 551,000 | SH | SOLE | 551,000 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 4,096 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Esperion Therapeutics, Inc. | Common | 29664W105 | 1,016 | 102,800 | SH | SOLE | 102,800 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 10,976 | 1,405,420 | SH | SOLE | 1,405,420 | 0 | 0 | ||
Flamel Technologies SA | Sponsored ADR | 338488109 | 6,705 | 624,288 | SH | SOLE | 624,288 | 0 | 0 | ||
Flex Pharm, Inc. | Common | 33938A105 | 1,655 | 162,124 | SH | SOLE | 162,124 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | Shares | M46135105 | 6,135 | 966,065 | SH | SOLE | 966,065 | 0 | 0 | ||
Forward Pharma A/S | Sponsored ADR | 34986J105 | 2,481 | 136,547 | SH | SOLE | 136,547 | 0 | 0 | ||
Galapagos NV | Sponsored ADR | 36315X101 | 8,195 | 147,738 | SH | SOLE | 147,738 | 0 | 0 | ||
GenMark Diagnostics, Inc. | Common | 372309104 | 812 | 93,349 | SH | SOLE | 93,349 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 209,529 | 2,511,731 | SH | SOLE | 2,511,731 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 4,788 | 57,400 | SH | Call | SOLE | 57,400 | 0 | 0 | |
GlaxoSmithKline plc | Common | 37733W105 | 3,259 | 75,200 | SH | Call | SOLE | 75,200 | 0 | 0 | |
GlaxoSmithKline plc | Sponsored ADR | 37733W105 | 18,818 | 434,200 | SH | SOLE | 434,200 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | Common | 37890U108 | 2,074 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Grifols SA | Sponsored ADR | 398438408 | 2,767 | 166,000 | SH | SOLE | 166,000 | 0 | 0 | ||
Halozyme Therapeutics, Inc. | Common | 40637H109 | 1,726 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
HCA Holdings, Inc. | Common | 40412C101 | 25,798 | 334,998 | SH | SOLE | 334,998 | 0 | 0 | ||
Heron Therapeutics, Inc. | Common | 427746102 | 8,886 | 492,303 | SH | SOLE | 492,303 | 0 | 0 | ||
Horizon Pharma plc | Shares | G4617B105 | 12,351 | 749,900 | SH | SOLE | 749,900 | 0 | 0 | ||
Humana Inc. | Common | 444859102 | 23,258 | 129,300 | SH | SOLE | 129,300 | 0 | 0 | ||
ICON plc | Shares | G4705A100 | 5,041 | 72,000 | SH | SOLE | 72,000 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 12,290 | 132,352 | SH | SOLE | 132,352 | 0 | 0 | ||
Illumina Inc. | Common | 452327109 | 52,132 | 371,364 | SH | SOLE | 371,364 | 0 | 0 | ||
Immunomedics, Inc. | Note 4.75% 2/15/20 | 452907AK4 | 2,715 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
Impax Laboratories, Inc. | Common | 45256B101 | 3,583 | 124,335 | SH | SOLE | 124,335 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 70,419 | 880,461 | SH | SOLE | 880,461 | 0 | 0 | ||
Inotek Pharmaceuticals Corporation | Common | 45780V102 | 1,345 | 180,762 | SH | SOLE | 180,762 | 0 | 0 | ||
Intellia Therapeutics, Inc. | Common | 45826J105 | 1,854 | 86,842 | SH | SOLE | 86,842 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 7,290 | 187,800 | SH | SOLE | 187,800 | 0 | 0 | ||
Ishares Nasdaq Biotechnology ETF | ETF | 464287556 | 14,841 | 57,670 | SH | SOLE | 57,670 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 22,108 | 156,451 | SH | SOLE | 156,451 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 40,916 | 337,312 | SH | SOLE | 337,312 | 0 | 0 | ||
Juno Therapeutics, Inc. | Common | 48205A109 | 6,996 | 182,000 | SH | SOLE | 182,000 | 0 | 0 | ||
Karyopharm Therapeutics, Inc. | Common | 48576U106 | 3,357 | 500,324 | SH | SOLE | 500,324 | 0 | 0 | ||
Kite Pharma, Inc. | Common | 49803L109 | 2,050 | 41,000 | SH | SOLE | 41,000 | 0 | 0 | ||
LTC Properties Inc. | Common | 502175102 | 5,494 | 106,212 | SH | SOLE | 106,212 | 0 | 0 | ||
Mallinckrodt plc | Shares | G5785G107 | 13,609 | 223,900 | SH | SOLE | 223,900 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 2,800 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 13,999 | 920,393 | SH | SOLE | 920,393 | 0 | 0 | ||
The Medicines Company | Common | 584668105 | 9,403 | 279,600 | SH | Call | SOLE | 279,600 | 0 | 0 | |
The Medicines Company | Common | 584688105 | 23,684 | 704,238 | SH | SOLE | 704,238 | 0 | 0 | ||
Medivation, Inc. | Common | 58501N101 | 15,475 | 256,638 | SH | SOLE | 256,638 | 0 | 0 | ||
Medivation, Inc. | Common | 58501N101 | 3,618 | 60,000 | SH | Call | SOLE | 60,000 | 0 | 0 | |
Medtronic plc | Shares | G5960L103 | 59,325 | 683,704 | SH | SOLE | 683,704 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 45,950 | 797,597 | SH | SOLE | 797,597 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Note 4.50% 7/15/20 | 590328AA8 | 1,654 | 1,485,000 | PRN | SOLE | 1,485,000 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Common | 590328100 | 1,542 | 286,000 | SH | SOLE | 286,000 | 0 | 0 | ||
Merus B.V. | Common | N5749R100 | 2,113 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
Molina Healthcare, Inc. | Common | 60855R100 | 26,841 | 537,901 | SH | SOLE | 537,901 | 0 | 0 | ||
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 1,660 | 153,700 | SH | SOLE | 153,700 | 0 | 0 | ||
Mylan NV | Shares | N59465109 | 31,243 | 722,552 | SH | SOLE | 722,552 | 0 | 0 | ||
Mylan NV | Shares | N59465109 | 4,523 | 104,600 | SH | Call | SOLE | 104,600 | 0 | 0 | |
Natera, Inc. | Common | 632307104 | 10,646 | 882,358 | SH | SOLE | 882,358 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 34,861 | 767,022 | SH | SOLE | 767,022 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 5,018 | 110,400 | SH | Call | SOLE | 110,400 | 0 | 0 | |
Nevro Corp. | Common | 64157F103 | 3,673 | 49,800 | SH | SOLE | 49,800 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 14,035 | 170,100 | SH | SOLE | 170,100 | 0 | 0 | ||
Novavax, Inc. | Common | 670002104 | 2,603 | 358,000 | SH | SOLE | 358,000 | 0 | 0 | ||
Omega Healthcare Investors Inc. | Common | 681936100 | 14,025 | 413,116 | SH | SOLE | 413,116 | 0 | 0 | ||
Paratek Pharmaceuticals, Inc. | Common | 699374302 | 10,608 | 762,581 | SH | SOLE | 762,581 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 3,382 | 37,300 | SH | SOLE | 37,300 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 52,227 | 1,483,291 | SH | SOLE | 1,483,291 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 11,149 | 530,672 | SH | SOLE | 530,672 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 6,196 | 3,848,191 | SH | SOLE | 3,848,191 | 0 | 0 | ||
PRA Health Sciences, Inc. | Common | 69354M108 | 4,260 | 102,000 | SH | SOLE | 102,000 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 7,751 | 260,200 | SH | SOLE | 260,200 | 0 | 0 | ||
Quorum Health Corp. | Common | 74909E106 | 815 | 76,118 | SH | SOLE | 76,118 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 53,874 | 154,266 | SH | SOLE | 154,266 | 0 | 0 | ||
Retrophin, Inc. | Common | 761299106 | 5,876 | 329,949 | SH | SOLE | 329,949 | 0 | 0 | ||
Revance Therapeutics, Inc. | Common | 761330109 | 1,020 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
The RMR Group Inc., Class A | Class A | 74967R106 | 230 | 7,441 | SH | SOLE | 7,441 | 0 | 0 | ||
Sabra Health Care REIT Inc. | Common | 78573L106 | 9,413 | 456,190 | SH | SOLE | 456,190 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 4,423 | 146,800 | SH | SOLE | 146,800 | 0 | 0 | ||
Sagent Pharmaceuticals, Inc. | Common | 786692103 | 4,294 | 286,650 | SH | SOLE | 286,650 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 12,764 | 305,000 | SH | SOLE | 305,000 | 0 | 0 | ||
Senior Housing Properties Trust | Shares | 81721M109 | 13,967 | 670,504 | SH | SOLE | 670,504 | 0 | 0 | ||
Shire plc | Sponsored ADR | 82481R106 | 37,131 | 201,713 | SH | SOLE | 201,713 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P Biotech | 78464A870 | 15,902 | 294,000 | SH | SOLE | 294,000 | 0 | 0 | ||
St. Jude Medical, Inc. | Common | 790849103 | 12,387 | 158,805 | SH | SOLE | 158,805 | 0 | 0 | ||
Supernus Pharmaceuticals, Inc. | Note 7.50% 5/1/19 | 868459AB4 | 7,688 | 2,000,000 | PRN | SOLE | 2,000,000 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 4,547 | 164,500 | SH | SOLE | 164,500 | 0 | 0 | ||
Tetraphase Pharmaceuticals Inc. | Common | 88165N105 | 827 | 192,322 | SH | SOLE | 192,322 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | ADR | 881624209 | 33,752 | 671,958 | SH | SOLE | 671,958 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 12,766 | 86,395 | SH | SOLE | 86,395 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 4,324 | 88,400 | SH | SOLE | 88,400 | 0 | 0 | ||
UniQure NV | Shares | N90064101 | 1,776 | 241,021 | SH | SOLE | 241,021 | 0 | 0 | ||
United Therapeutics Corporation | Common | 91307C102 | 9,861 | 93,100 | SH | SOLE | 93,100 | 0 | 0 | ||
UnitedHealth Group, Inc. | Common | 91324P102 | 46,751 | 331,100 | SH | SOLE | 331,100 | 0 | 0 | ||
Universal Health Services, Inc. | Class B | 913903100 | 18,061 | 134,680 | SH | SOLE | 134,680 | 0 | 0 | ||
Valeant Pharmaceuticals International, Inc. | Common | 91911K102 | 3,867 | 192,000 | SH | SOLE | 192,000 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 11,104 | 152,491 | SH | SOLE | 152,491 | 0 | 0 | ||
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 88,902 | 1,033,503 | SH | SOLE | 1,033,503 | 0 | 0 | ||
Welltower, Inc. | Preferred Convertible | 95040Q203 | 13,560 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Wright Medical Group NV | Ordinary Shares | N96617118 | 6,999 | 402,950 | SH | SOLE | 402,950 | 0 | 0 | ||
Wright Medical Group NV | Ordinary Shares | N96617118 | 2,936 | 169,000 | SH | Call | SOLE | 169,000 | 0 | 0 | |
Xencor, Inc. | Common | 98401F105 | 380 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Zafgen, Inc. | Common | 98885E103 | 80 | 13,307 | SH | SOLE | 13,307 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 12,315 | 102,300 | SH | SOLE | 102,300 | 0 | 0 |